Seven challenges for nanomedicine (original) (raw)

Nature Nanotechnology volume 3, pages 242–244 (2008)Cite this article

Nanomedicine offers new opportunities to fight diseases but a global effort is needed to safely translate laboratory innovation to the clinic. Seven priority areas have been identified for this endeavour.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

References

  1. Ferrari, M. Nat. Rev. Cancer 5, 161–171 (2005).
    Article CAS Google Scholar
  2. LaVan, D.A., McGuire, T. & Langer, R. Nat. Biotechnol. 21, 1184–1191 (2003).
    Article CAS Google Scholar
  3. Heath, J.R., Phelps, M.E. & Hood, L. Mol. Imag. Biol. 5, 312–25 (2003).
    Article Google Scholar
  4. Nam, J.M., Stoeva, S.I. & Mirkin, C.A. J. Am. Chem. Soc. 126, 5932–3 (2004).
    Article CAS Google Scholar
  5. Sanhai, W.R., Spiegel, J. & Ferrari, M. Drug Discovery Today: Technologies 4, 35–41 (2007).
    Article Google Scholar
  6. Liu, Z. et al. Proc. Natl Acad. Sci. USA 105, 1410–5 (2008).
    Article CAS Google Scholar
  7. Rabin, O., Perez, J.M., Grimm, J., Wojtkiewicz, G. & Weissleder, R. Nature Mater. 5, 118–122 (2006).
    Article CAS Google Scholar
  8. Hargreaves, R. J. Clin. Pharmacol. Ther. 83, 349–53 (2008).
    Article CAS Google Scholar
  9. Brindle, K. Nat. Rev. Cancer 8, 94–107 (2008).
    Article CAS Google Scholar
  10. Tasciotti, E. et al. Nature Nanotech. 3, 151–157 (2008).
    Article CAS Google Scholar
  11. Peer, D. et al. Nature Nanotech. 2, 751–760 (2007).
    Article CAS Google Scholar
  12. Ferrari, M. Small 4, 20–25 (2008).
    Article CAS Google Scholar
  13. Browning, L.D. & Shetler, J.C. Sematech: saving the US semiconductor industry (Texas A&M University Press, College Station, Texas, 2000).
    Google Scholar

Download references

Author information

Authors and Affiliations

  1. The Office of the Commissioner, Food & Drug Administration, Rockville, 20857, Maryland, USA
    Wendy R. Sanhai
  2. Nanomedicine, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, 77030, Texas, USA
    Jason H. Sakamoto & Mauro Ferrari
  3. Office of Science and Health Coordination, Food & Drug Administration, Rockville, 20857, Maryland, USA
    Richard Canady
  4. Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, 77030, Texas, USA
    Mauro Ferrari
  5. Department of Bioengineering, Rice University, Houston, 77005, Texas, USA
    Mauro Ferrari

Authors

  1. Wendy R. Sanhai
    You can also search for this author inPubMed Google Scholar
  2. Jason H. Sakamoto
    You can also search for this author inPubMed Google Scholar
  3. Richard Canady
    You can also search for this author inPubMed Google Scholar
  4. Mauro Ferrari
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toMauro Ferrari.

Supplementary information

Rights and permissions

About this article

Cite this article

Sanhai, W., Sakamoto, J., Canady, R. et al. Seven challenges for nanomedicine.Nature Nanotech 3, 242–244 (2008). https://doi.org/10.1038/nnano.2008.114

Download citation

This article is cited by